Topical spironolactone is discussed for hair loss treatment, with mentions of DIY solutions and dermatologistcompounding. Users inquire about regrowth and sourcing the treatment.
In Austria, finasteride prescriptions are restricted due to suicide risk concerns, with new prescriptions only for current users. Alternatives like topical finasteride, dutasteride, and online purchases face legal challenges.
A 23-year-old Italian man in Switzerland is experiencing hair loss and cannot get a prescription for Finasteride, only Minoxidil. He seeks advice on obtaining Finasteride through online pharmacies or by consulting different doctors.
Concerns about hair loss treatments, specifically finasteride and minoxidil, and doubts about a bald dermatologist prescribing them. Users recommend finding a dermatologist who prescribes effective treatments or exploring online options for finasteride.
A user seeks a topical hair loss treatment without minoxidil, considering options like finasteride, dutasteride, caffeine, tretinoin, or prostaglandin analogues. Recommendations include products like Strut, Maximus, Zeuss, and custom formulas from compounding pharmacies.
1 citations
,
November 2018 in “Dermatologic Therapy”
This report describes the use of compounded topical preparations to treat two severe psoriasis patients and calls for further studies on their regulation, protocol, and stability evaluation.
54 citations
,
September 2012 in “Dermatologic Clinics”
This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.
1 citations
,
October 2013 in “Actas Dermo-Sifiliográficas”
This review discusses the current role and challenges of compounding in dermatology without presenting new research results; the authors suggest its resurgence in practice despite pharmaceutical alternatives.
This review found an increased prevalence of common skin disorders, such as infectious and inflammatory conditions, in patients with Down syndrome and highlighted the need for improved screening and management guidelines.
September 2016 in “Annals of occupational and environmental medicine”
In this study, cleanroom workers in a secondary battery factory reported worse dermatologic life quality compared to non-cleanroom workers, as measured by the Skindex-29 questionnaire.